(Total Views: 73)
Posted On: 11/21/2019 2:50:42 PM
Post# of 74551

$PVCT News Article - Provectus Announces Presentation of Initial Results from Phase 1B Trial of PV-10 in Combination with KEYTRUDA for Treatment of Checkpoint-Refractory Advanced Melanoma at SMR 2019 Congress https://marketwirenews.com/news-releases/prov...39909.html


My Twitter: WhyteStocks